PIGO

Chr 9AR

phosphatidylinositol glycan anchor biosynthesis class O

The protein transfers ethanolaminephosphate to the third mannose in glycosylphosphatidylinositol (GPI) anchor biosynthesis, which anchors proteins to cell surfaces including blood cells. Autosomal recessive mutations cause hyperphosphatasia with impaired intellectual development syndrome 2. The pathogenic mechanism involves loss of function leading to defective GPI anchor formation.

OMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismARLOEUF 0.811 OMIM phenotype
Clinical SummaryPIGO
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
45 unique Pathogenic / Likely Pathogenic· 164 VUS of 400 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.81LOEUF
pLI 0.000
Z-score 2.50
OE 0.57 (0.410.81)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.96Z-score
OE missense 0.89 (0.830.96)
549 obs / 615.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.57 (0.410.81)
00.351.4
Missense OE0.89 (0.830.96)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 23 / 40.1Missense obs/exp: 549 / 615.8Syn Z: -0.94
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePIGO-related hyperphosphatasia with intellectual developmental disorder syndromeLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7133th %ile
GOF
0.5760th %ile
LOF
0.2969th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic8
VUS164
Likely Benign174
Benign1
37
Pathogenic
8
Likely Pathogenic
164
VUS
174
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
28
0
9
0
37
Likely Pathogenic
4
1
3
0
8
VUS
1
151
10
2
164
Likely Benign
0
1
44
129
174
Benign
0
1
0
0
1
Total3315466131384

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PIGO · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →